nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—POR—Doxorubicin—sarcoma	0.331	0.38	CbGbCtD
Nitrofurantoin—ABCG2—Dactinomycin—sarcoma	0.156	0.179	CbGbCtD
Nitrofurantoin—ABCG2—Mitoxantrone—sarcoma	0.14	0.16	CbGbCtD
Nitrofurantoin—ABCG2—Vincristine—sarcoma	0.096	0.11	CbGbCtD
Nitrofurantoin—ABCG2—Etoposide—sarcoma	0.088	0.101	CbGbCtD
Nitrofurantoin—ABCG2—Doxorubicin—sarcoma	0.06	0.0689	CbGbCtD
Nitrofurantoin—Chills—Dactinomycin—sarcoma	0.000568	0.00438	CcSEcCtD
Nitrofurantoin—Alopecia—Thiotepa—sarcoma	0.000564	0.00435	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Vincristine—sarcoma	0.000563	0.00434	CcSEcCtD
Nitrofurantoin—Alopecia—Dactinomycin—sarcoma	0.000559	0.00432	CcSEcCtD
Nitrofurantoin—Hepatitis—Mitoxantrone—sarcoma	0.000551	0.00425	CcSEcCtD
Nitrofurantoin—Jaundice cholestatic—Doxorubicin—sarcoma	0.000538	0.00415	CcSEcCtD
Nitrofurantoin—Anaemia—Thiotepa—sarcoma	0.000513	0.00396	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Dactinomycin—sarcoma	0.000511	0.00394	CcSEcCtD
Nitrofurantoin—Anaemia—Dactinomycin—sarcoma	0.000509	0.00393	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Etoposide—sarcoma	0.000506	0.0039	CcSEcCtD
Nitrofurantoin—Renal failure—Etoposide—sarcoma	0.000502	0.00387	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Etoposide—sarcoma	0.0005	0.00386	CcSEcCtD
Nitrofurantoin—Alopecia—Vincristine—sarcoma	0.0005	0.00386	CcSEcCtD
Nitrofurantoin—Leukopenia—Thiotepa—sarcoma	0.000497	0.00383	CcSEcCtD
Nitrofurantoin—Malaise—Dactinomycin—sarcoma	0.000497	0.00383	CcSEcCtD
Nitrofurantoin—Chills—Mitoxantrone—sarcoma	0.000494	0.00381	CcSEcCtD
Nitrofurantoin—Leukopenia—Dactinomycin—sarcoma	0.000493	0.00381	CcSEcCtD
Nitrofurantoin—Alopecia—Mitoxantrone—sarcoma	0.000487	0.00376	CcSEcCtD
Nitrofurantoin—Cough—Thiotepa—sarcoma	0.000484	0.00374	CcSEcCtD
Nitrofurantoin—Aplastic anaemia—Epirubicin—sarcoma	0.00048	0.0037	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Etoposide—sarcoma	0.000476	0.00367	CcSEcCtD
Nitrofurantoin—Myalgia—Thiotepa—sarcoma	0.000473	0.00365	CcSEcCtD
Nitrofurantoin—Myalgia—Dactinomycin—sarcoma	0.000469	0.00362	CcSEcCtD
Nitrofurantoin—Discomfort—Dactinomycin—sarcoma	0.000463	0.00358	CcSEcCtD
Nitrofurantoin—Confusional state—Thiotepa—sarcoma	0.000457	0.00353	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Etoposide—sarcoma	0.000456	0.00352	CcSEcCtD
Nitrofurantoin—Anaemia—Vincristine—sarcoma	0.000455	0.00351	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Mitoxantrone—sarcoma	0.000445	0.00343	CcSEcCtD
Nitrofurantoin—Aplastic anaemia—Doxorubicin—sarcoma	0.000444	0.00343	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Thiotepa—sarcoma	0.000444	0.00342	CcSEcCtD
Nitrofurantoin—Anaemia—Mitoxantrone—sarcoma	0.000443	0.00342	CcSEcCtD
Nitrofurantoin—Vertigo—Vincristine—sarcoma	0.000442	0.00341	CcSEcCtD
Nitrofurantoin—Leukopenia—Vincristine—sarcoma	0.000441	0.0034	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Dactinomycin—sarcoma	0.00044	0.0034	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Etoposide—sarcoma	0.000433	0.00334	CcSEcCtD
Nitrofurantoin—Malaise—Mitoxantrone—sarcoma	0.000432	0.00334	CcSEcCtD
Nitrofurantoin—Anorexia—Thiotepa—sarcoma	0.000432	0.00333	CcSEcCtD
Nitrofurantoin—Leukopenia—Mitoxantrone—sarcoma	0.000429	0.00331	CcSEcCtD
Nitrofurantoin—Anorexia—Dactinomycin—sarcoma	0.000429	0.00331	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Epirubicin—sarcoma	0.000427	0.00329	CcSEcCtD
Nitrofurantoin—Myalgia—Vincristine—sarcoma	0.000419	0.00323	CcSEcCtD
Nitrofurantoin—Cough—Mitoxantrone—sarcoma	0.000418	0.00323	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000413	0.00319	CcSEcCtD
Nitrofurantoin—Chills—Etoposide—sarcoma	0.000411	0.00317	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00041	0.00316	CcSEcCtD
Nitrofurantoin—Chest pain—Mitoxantrone—sarcoma	0.000408	0.00315	CcSEcCtD
Nitrofurantoin—Myalgia—Mitoxantrone—sarcoma	0.000408	0.00315	CcSEcCtD
Nitrofurantoin—Paraesthesia—Thiotepa—sarcoma	0.000407	0.00314	CcSEcCtD
Nitrofurantoin—Alopecia—Etoposide—sarcoma	0.000405	0.00312	CcSEcCtD
Nitrofurantoin—Discomfort—Mitoxantrone—sarcoma	0.000403	0.00311	CcSEcCtD
Nitrofurantoin—Somnolence—Thiotepa—sarcoma	0.000403	0.00311	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Vincristine—sarcoma	0.000402	0.0031	CcSEcCtD
Nitrofurantoin—Dyspepsia—Thiotepa—sarcoma	0.000399	0.00308	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Doxorubicin—sarcoma	0.000395	0.00305	CcSEcCtD
Nitrofurantoin—Confusional state—Mitoxantrone—sarcoma	0.000395	0.00304	CcSEcCtD
Nitrofurantoin—Decreased appetite—Thiotepa—sarcoma	0.000394	0.00304	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Epirubicin—sarcoma	0.000393	0.00304	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Vincristine—sarcoma	0.000393	0.00304	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Mitoxantrone—sarcoma	0.000391	0.00302	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Thiotepa—sarcoma	0.000391	0.00302	CcSEcCtD
Nitrofurantoin—Decreased appetite—Dactinomycin—sarcoma	0.000391	0.00302	CcSEcCtD
Nitrofurantoin—Renal impairment—Epirubicin—sarcoma	0.00039	0.00301	CcSEcCtD
Nitrofurantoin—Constipation—Thiotepa—sarcoma	0.000387	0.00299	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Mitoxantrone—sarcoma	0.000383	0.00296	CcSEcCtD
Nitrofurantoin—Anorexia—Vincristine—sarcoma	0.000383	0.00296	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Thiotepa—sarcoma	0.000373	0.00288	CcSEcCtD
Nitrofurantoin—Anorexia—Mitoxantrone—sarcoma	0.000373	0.00288	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Dactinomycin—sarcoma	0.000371	0.00286	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Thiotepa—sarcoma	0.000371	0.00286	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Etoposide—sarcoma	0.00037	0.00285	CcSEcCtD
Nitrofurantoin—Anaemia—Etoposide—sarcoma	0.000369	0.00284	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Dactinomycin—sarcoma	0.000368	0.00284	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Vincristine—sarcoma	0.000366	0.00282	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Doxorubicin—sarcoma	0.000364	0.00281	CcSEcCtD
Nitrofurantoin—Renal impairment—Doxorubicin—sarcoma	0.000361	0.00278	CcSEcCtD
Nitrofurantoin—Paraesthesia—Vincristine—sarcoma	0.000361	0.00278	CcSEcCtD
Nitrofurantoin—Malaise—Etoposide—sarcoma	0.00036	0.00277	CcSEcCtD
Nitrofurantoin—Vertigo—Etoposide—sarcoma	0.000358	0.00276	CcSEcCtD
Nitrofurantoin—Abdominal pain—Thiotepa—sarcoma	0.000358	0.00276	CcSEcCtD
Nitrofurantoin—Body temperature increased—Thiotepa—sarcoma	0.000358	0.00276	CcSEcCtD
Nitrofurantoin—Leukopenia—Etoposide—sarcoma	0.000357	0.00275	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000356	0.00275	CcSEcCtD
Nitrofurantoin—Body temperature increased—Dactinomycin—sarcoma	0.000355	0.00274	CcSEcCtD
Nitrofurantoin—Abdominal pain—Dactinomycin—sarcoma	0.000355	0.00274	CcSEcCtD
Nitrofurantoin—Paraesthesia—Mitoxantrone—sarcoma	0.000351	0.00271	CcSEcCtD
Nitrofurantoin—Decreased appetite—Vincristine—sarcoma	0.000349	0.00269	CcSEcCtD
Nitrofurantoin—Dyspnoea—Mitoxantrone—sarcoma	0.000349	0.00269	CcSEcCtD
Nitrofurantoin—Cough—Etoposide—sarcoma	0.000348	0.00269	CcSEcCtD
Nitrofurantoin—Somnolence—Mitoxantrone—sarcoma	0.000348	0.00268	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Vincristine—sarcoma	0.000347	0.00268	CcSEcCtD
Nitrofurantoin—Dyspepsia—Mitoxantrone—sarcoma	0.000344	0.00266	CcSEcCtD
Nitrofurantoin—Constipation—Vincristine—sarcoma	0.000344	0.00265	CcSEcCtD
Nitrofurantoin—Decreased appetite—Mitoxantrone—sarcoma	0.00034	0.00262	CcSEcCtD
Nitrofurantoin—Chest pain—Etoposide—sarcoma	0.00034	0.00262	CcSEcCtD
Nitrofurantoin—Discomfort—Etoposide—sarcoma	0.000335	0.00259	CcSEcCtD
Nitrofurantoin—Constipation—Mitoxantrone—sarcoma	0.000335	0.00258	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000334	0.00258	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Thiotepa—sarcoma	0.000334	0.00258	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Dactinomycin—sarcoma	0.000331	0.00256	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Vincristine—sarcoma	0.000329	0.00254	CcSEcCtD
Nitrofurantoin—Confusional state—Etoposide—sarcoma	0.000328	0.00253	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000327	0.00253	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Etoposide—sarcoma	0.000325	0.00251	CcSEcCtD
Nitrofurantoin—Asthenia—Thiotepa—sarcoma	0.000325	0.00251	CcSEcCtD
Nitrofurantoin—Asthenia—Dactinomycin—sarcoma	0.000323	0.00249	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Mitoxantrone—sarcoma	0.000322	0.00249	CcSEcCtD
Nitrofurantoin—Asthma—Epirubicin—sarcoma	0.000321	0.00248	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00032	0.00247	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Etoposide—sarcoma	0.000319	0.00246	CcSEcCtD
Nitrofurantoin—Eosinophilia—Epirubicin—sarcoma	0.000318	0.00245	CcSEcCtD
Nitrofurantoin—Body temperature increased—Vincristine—sarcoma	0.000318	0.00245	CcSEcCtD
Nitrofurantoin—Abdominal pain—Vincristine—sarcoma	0.000318	0.00245	CcSEcCtD
Nitrofurantoin—Anorexia—Etoposide—sarcoma	0.00031	0.00239	CcSEcCtD
Nitrofurantoin—Diarrhoea—Thiotepa—sarcoma	0.00031	0.00239	CcSEcCtD
Nitrofurantoin—Abdominal pain—Mitoxantrone—sarcoma	0.000309	0.00239	CcSEcCtD
Nitrofurantoin—Body temperature increased—Mitoxantrone—sarcoma	0.000309	0.00239	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000309	0.00239	CcSEcCtD
Nitrofurantoin—Diarrhoea—Dactinomycin—sarcoma	0.000308	0.00237	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000303	0.00234	CcSEcCtD
Nitrofurantoin—Dizziness—Thiotepa—sarcoma	0.0003	0.00231	CcSEcCtD
Nitrofurantoin—Asthma—Doxorubicin—sarcoma	0.000297	0.00229	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Vincristine—sarcoma	0.000296	0.00228	CcSEcCtD
Nitrofurantoin—Eosinophilia—Doxorubicin—sarcoma	0.000294	0.00227	CcSEcCtD
Nitrofurantoin—Paraesthesia—Etoposide—sarcoma	0.000292	0.00225	CcSEcCtD
Nitrofurantoin—Dyspnoea—Etoposide—sarcoma	0.00029	0.00224	CcSEcCtD
Nitrofurantoin—Somnolence—Etoposide—sarcoma	0.000289	0.00223	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Mitoxantrone—sarcoma	0.000288	0.00222	CcSEcCtD
Nitrofurantoin—Asthenia—Vincristine—sarcoma	0.000288	0.00222	CcSEcCtD
Nitrofurantoin—Vomiting—Thiotepa—sarcoma	0.000288	0.00222	CcSEcCtD
Nitrofurantoin—Drowsiness—Epirubicin—sarcoma	0.000286	0.00221	CcSEcCtD
Nitrofurantoin—Vomiting—Dactinomycin—sarcoma	0.000286	0.00221	CcSEcCtD
Nitrofurantoin—Rash—Thiotepa—sarcoma	0.000286	0.0022	CcSEcCtD
Nitrofurantoin—Headache—Thiotepa—sarcoma	0.000284	0.00219	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000284	0.00219	CcSEcCtD
Nitrofurantoin—Rash—Dactinomycin—sarcoma	0.000284	0.00219	CcSEcCtD
Nitrofurantoin—Decreased appetite—Etoposide—sarcoma	0.000283	0.00218	CcSEcCtD
Nitrofurantoin—Renal failure—Epirubicin—sarcoma	0.000281	0.00217	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Etoposide—sarcoma	0.000281	0.00217	CcSEcCtD
Nitrofurantoin—Asthenia—Mitoxantrone—sarcoma	0.000281	0.00217	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Epirubicin—sarcoma	0.00028	0.00216	CcSEcCtD
Nitrofurantoin—Constipation—Etoposide—sarcoma	0.000278	0.00215	CcSEcCtD
Nitrofurantoin—Diarrhoea—Vincristine—sarcoma	0.000275	0.00212	CcSEcCtD
Nitrofurantoin—Nausea—Thiotepa—sarcoma	0.000269	0.00208	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Etoposide—sarcoma	0.000268	0.00207	CcSEcCtD
Nitrofurantoin—Diarrhoea—Mitoxantrone—sarcoma	0.000268	0.00207	CcSEcCtD
Nitrofurantoin—Nausea—Dactinomycin—sarcoma	0.000267	0.00206	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Epirubicin—sarcoma	0.000267	0.00206	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Etoposide—sarcoma	0.000266	0.00205	CcSEcCtD
Nitrofurantoin—Dizziness—Vincristine—sarcoma	0.000266	0.00205	CcSEcCtD
Nitrofurantoin—Drowsiness—Doxorubicin—sarcoma	0.000265	0.00204	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000262	0.00202	CcSEcCtD
Nitrofurantoin—Renal failure—Doxorubicin—sarcoma	0.00026	0.00201	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Doxorubicin—sarcoma	0.000259	0.002	CcSEcCtD
Nitrofurantoin—Abdominal pain—Etoposide—sarcoma	0.000257	0.00199	CcSEcCtD
Nitrofurantoin—Body temperature increased—Etoposide—sarcoma	0.000257	0.00199	CcSEcCtD
Nitrofurantoin—Hepatitis—Epirubicin—sarcoma	0.000257	0.00198	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Epirubicin—sarcoma	0.000256	0.00197	CcSEcCtD
Nitrofurantoin—Vomiting—Vincristine—sarcoma	0.000255	0.00197	CcSEcCtD
Nitrofurantoin—Rash—Vincristine—sarcoma	0.000253	0.00195	CcSEcCtD
Nitrofurantoin—Headache—Vincristine—sarcoma	0.000252	0.00194	CcSEcCtD
Nitrofurantoin—Vomiting—Mitoxantrone—sarcoma	0.000249	0.00192	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Doxorubicin—sarcoma	0.000247	0.00191	CcSEcCtD
Nitrofurantoin—Rash—Mitoxantrone—sarcoma	0.000247	0.0019	CcSEcCtD
Nitrofurantoin—Headache—Mitoxantrone—sarcoma	0.000245	0.00189	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Epirubicin—sarcoma	0.000243	0.00187	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Etoposide—sarcoma	0.00024	0.00185	CcSEcCtD
Nitrofurantoin—Nausea—Vincristine—sarcoma	0.000239	0.00184	CcSEcCtD
Nitrofurantoin—Hepatitis—Doxorubicin—sarcoma	0.000238	0.00183	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Doxorubicin—sarcoma	0.000236	0.00182	CcSEcCtD
Nitrofurantoin—Asthenia—Etoposide—sarcoma	0.000234	0.0018	CcSEcCtD
Nitrofurantoin—Nausea—Mitoxantrone—sarcoma	0.000232	0.00179	CcSEcCtD
Nitrofurantoin—Chills—Epirubicin—sarcoma	0.00023	0.00178	CcSEcCtD
Nitrofurantoin—Alopecia—Epirubicin—sarcoma	0.000227	0.00175	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Doxorubicin—sarcoma	0.000225	0.00173	CcSEcCtD
Nitrofurantoin—Diarrhoea—Etoposide—sarcoma	0.000223	0.00172	CcSEcCtD
Nitrofurantoin—Flatulence—Epirubicin—sarcoma	0.00022	0.0017	CcSEcCtD
Nitrofurantoin—Dizziness—Etoposide—sarcoma	0.000215	0.00166	CcSEcCtD
Nitrofurantoin—Chills—Doxorubicin—sarcoma	0.000213	0.00164	CcSEcCtD
Nitrofurantoin—Alopecia—Doxorubicin—sarcoma	0.00021	0.00162	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Epirubicin—sarcoma	0.000207	0.0016	CcSEcCtD
Nitrofurantoin—Vomiting—Etoposide—sarcoma	0.000207	0.0016	CcSEcCtD
Nitrofurantoin—Anaemia—Epirubicin—sarcoma	0.000207	0.00159	CcSEcCtD
Nitrofurantoin—Rash—Etoposide—sarcoma	0.000205	0.00158	CcSEcCtD
Nitrofurantoin—Headache—Etoposide—sarcoma	0.000204	0.00157	CcSEcCtD
Nitrofurantoin—Flatulence—Doxorubicin—sarcoma	0.000204	0.00157	CcSEcCtD
Nitrofurantoin—Malaise—Epirubicin—sarcoma	0.000202	0.00156	CcSEcCtD
Nitrofurantoin—Vertigo—Epirubicin—sarcoma	0.000201	0.00155	CcSEcCtD
Nitrofurantoin—Leukopenia—Epirubicin—sarcoma	0.0002	0.00154	CcSEcCtD
Nitrofurantoin—Cough—Epirubicin—sarcoma	0.000195	0.00151	CcSEcCtD
Nitrofurantoin—Nausea—Etoposide—sarcoma	0.000193	0.00149	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Doxorubicin—sarcoma	0.000192	0.00148	CcSEcCtD
Nitrofurantoin—Anaemia—Doxorubicin—sarcoma	0.000191	0.00148	CcSEcCtD
Nitrofurantoin—Chest pain—Epirubicin—sarcoma	0.00019	0.00147	CcSEcCtD
Nitrofurantoin—Myalgia—Epirubicin—sarcoma	0.00019	0.00147	CcSEcCtD
Nitrofurantoin—Discomfort—Epirubicin—sarcoma	0.000188	0.00145	CcSEcCtD
Nitrofurantoin—Malaise—Doxorubicin—sarcoma	0.000187	0.00144	CcSEcCtD
Nitrofurantoin—Vertigo—Doxorubicin—sarcoma	0.000186	0.00143	CcSEcCtD
Nitrofurantoin—Leukopenia—Doxorubicin—sarcoma	0.000185	0.00143	CcSEcCtD
Nitrofurantoin—Confusional state—Epirubicin—sarcoma	0.000184	0.00142	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Epirubicin—sarcoma	0.000182	0.00141	CcSEcCtD
Nitrofurantoin—Cough—Doxorubicin—sarcoma	0.00018	0.00139	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Epirubicin—sarcoma	0.000179	0.00138	CcSEcCtD
Nitrofurantoin—Myalgia—Doxorubicin—sarcoma	0.000176	0.00136	CcSEcCtD
Nitrofurantoin—Chest pain—Doxorubicin—sarcoma	0.000176	0.00136	CcSEcCtD
Nitrofurantoin—Discomfort—Doxorubicin—sarcoma	0.000174	0.00134	CcSEcCtD
Nitrofurantoin—Anorexia—Epirubicin—sarcoma	0.000174	0.00134	CcSEcCtD
Nitrofurantoin—Confusional state—Doxorubicin—sarcoma	0.00017	0.00131	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Doxorubicin—sarcoma	0.000169	0.0013	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000166	0.00128	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Doxorubicin—sarcoma	0.000165	0.00128	CcSEcCtD
Nitrofurantoin—Paraesthesia—Epirubicin—sarcoma	0.000164	0.00126	CcSEcCtD
Nitrofurantoin—Dyspnoea—Epirubicin—sarcoma	0.000163	0.00126	CcSEcCtD
Nitrofurantoin—Somnolence—Epirubicin—sarcoma	0.000162	0.00125	CcSEcCtD
Nitrofurantoin—Anorexia—Doxorubicin—sarcoma	0.000161	0.00124	CcSEcCtD
Nitrofurantoin—Dyspepsia—Epirubicin—sarcoma	0.000161	0.00124	CcSEcCtD
Nitrofurantoin—Decreased appetite—Epirubicin—sarcoma	0.000159	0.00122	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000158	0.00122	CcSEcCtD
Nitrofurantoin—Constipation—Epirubicin—sarcoma	0.000156	0.0012	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000154	0.00119	CcSEcCtD
Nitrofurantoin—Paraesthesia—Doxorubicin—sarcoma	0.000152	0.00117	CcSEcCtD
Nitrofurantoin—Dyspnoea—Doxorubicin—sarcoma	0.000151	0.00116	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Epirubicin—sarcoma	0.00015	0.00116	CcSEcCtD
Nitrofurantoin—Somnolence—Doxorubicin—sarcoma	0.00015	0.00116	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Epirubicin—sarcoma	0.000149	0.00115	CcSEcCtD
Nitrofurantoin—Dyspepsia—Doxorubicin—sarcoma	0.000149	0.00115	CcSEcCtD
Nitrofurantoin—Decreased appetite—Doxorubicin—sarcoma	0.000147	0.00113	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000146	0.00112	CcSEcCtD
Nitrofurantoin—Constipation—Doxorubicin—sarcoma	0.000144	0.00111	CcSEcCtD
Nitrofurantoin—Body temperature increased—Epirubicin—sarcoma	0.000144	0.00111	CcSEcCtD
Nitrofurantoin—Abdominal pain—Epirubicin—sarcoma	0.000144	0.00111	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Doxorubicin—sarcoma	0.000139	0.00107	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000138	0.00107	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Epirubicin—sarcoma	0.000134	0.00104	CcSEcCtD
Nitrofurantoin—Abdominal pain—Doxorubicin—sarcoma	0.000133	0.00103	CcSEcCtD
Nitrofurantoin—Body temperature increased—Doxorubicin—sarcoma	0.000133	0.00103	CcSEcCtD
Nitrofurantoin—Asthenia—Epirubicin—sarcoma	0.000131	0.00101	CcSEcCtD
Nitrofurantoin—Diarrhoea—Epirubicin—sarcoma	0.000125	0.000963	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Doxorubicin—sarcoma	0.000124	0.00096	CcSEcCtD
Nitrofurantoin—Asthenia—Doxorubicin—sarcoma	0.000121	0.000935	CcSEcCtD
Nitrofurantoin—Dizziness—Epirubicin—sarcoma	0.000121	0.000931	CcSEcCtD
Nitrofurantoin—Vomiting—Epirubicin—sarcoma	0.000116	0.000895	CcSEcCtD
Nitrofurantoin—Diarrhoea—Doxorubicin—sarcoma	0.000116	0.000891	CcSEcCtD
Nitrofurantoin—Rash—Epirubicin—sarcoma	0.000115	0.000888	CcSEcCtD
Nitrofurantoin—Headache—Epirubicin—sarcoma	0.000114	0.000882	CcSEcCtD
Nitrofurantoin—Dizziness—Doxorubicin—sarcoma	0.000112	0.000861	CcSEcCtD
Nitrofurantoin—Nausea—Epirubicin—sarcoma	0.000108	0.000836	CcSEcCtD
Nitrofurantoin—Vomiting—Doxorubicin—sarcoma	0.000107	0.000828	CcSEcCtD
Nitrofurantoin—Rash—Doxorubicin—sarcoma	0.000106	0.000821	CcSEcCtD
Nitrofurantoin—Headache—Doxorubicin—sarcoma	0.000106	0.000816	CcSEcCtD
Nitrofurantoin—Nausea—Doxorubicin—sarcoma	0.0001	0.000774	CcSEcCtD
